Translation and Psychometric Properties of the Arabic Version of Michigan Neuropathy Screening Instrument in Type 2 Diabetes.
Journal
Journal of diabetes research
ISSN: 2314-6753
Titre abrégé: J Diabetes Res
Pays: England
ID NLM: 101605237
Informations de publication
Date de publication:
2019
2019
Historique:
received:
18
11
2018
revised:
08
02
2019
accepted:
25
03
2019
entrez:
4
5
2019
pubmed:
3
5
2019
medline:
26
11
2019
Statut:
epublish
Résumé
To translate the patient questionnaire section of the Michigan Neuropathy Screening Instrument (MNSI) into Arabic, examine the reliability of the translated version, and provide descriptive data on a sample of patients with type 2 diabetes. Researchers used the translation-back translation method to obtain MNSI Arabic. The test was then applied on 76 patients with type 2 diabetes. A subgroup of 25 patients answered MNSI Arabic twice to examine reliability. The intraclass correlation coefficient was 0.87, revealing good reliability of MNSI Arabic. The most common symptoms patients complained of were numbness (62%), prickling feelings (57%), burning pain (47%), and pain with walking (46%). Similar to the original MNSI version, our study demonstrates that the Arabic version of the MNSI questionnaire is a reliable tool for screening the symptomatic neuropathy status in patients with type 2 diabetes. Availability of this tool in Arabic will provide valuable and easy-to-obtain screening information regarding diabetic peripheral neuropathy that may help delay its complications by promoting early management.
Identifiants
pubmed: 31049355
doi: 10.1155/2019/2673105
pmc: PMC6462346
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2673105Références
Diabetes Care. 2001 Feb;24(2):250-6
pubmed: 11213874
N Engl J Med. 2004 Jul 1;351(1):48-55
pubmed: 15229307
Postgrad Med J. 2006 Feb;82(964):95-100
pubmed: 16461471
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
Ann Saudi Med. 2007 Jan-Feb;27(1):25-31
pubmed: 17277500
J Diabetes Complications. 2008 Sep-Oct;22(5):317-24
pubmed: 18413210
J Vasc Surg. 2009 Sep;50(3):675-82, 682.e1
pubmed: 19595541
Diabetes Care. 2010 May;33(5):1090-6
pubmed: 20150297
Diabetes Care. 2010 Oct;33(10):2285-93
pubmed: 20876709
Diabet Med. 2012 Jul;29(7):937-44
pubmed: 22417277
J Neurol. 2012 Dec;259(12):2681-94
pubmed: 22729386
Neurol Res. 2012 Dec;34(10):960-6
pubmed: 23146298
J Diabetes Metab Disord. 2014 Jan 28;13(1):19
pubmed: 24472435
Diabetes Technol Ther. 2015 Jun;17(6):405-12
pubmed: 25664904
Diabetes Metab Syndr. 2015 Apr-Jun;9(2):79-84
pubmed: 25813140
Lancet. 2016 Apr 9;387(10027):1513-30
pubmed: 27061677
Diabetes Care. 2017 Jan;40(Suppl 1):S88-S98
pubmed: 27979897
Diabetes Care. 2017 Jan;40(1):136-154
pubmed: 27999003
Neurosci Biobehav Rev. 2017 Mar;74(Pt A):185-203
pubmed: 28108416
J Diabetes Res. 2017;2017:6719239
pubmed: 28373993
Diabetes Care. 2017 Sep;40(9):1226-1232
pubmed: 28674076
Diabetes Res Clin Pract. 2018 May;139:81-90
pubmed: 29477503
Diabetol Metab Syndr. 2018 Feb 21;10:8
pubmed: 29483946
Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
Diabetes Res Clin Pract. 2018 May;139:147-154
pubmed: 29518491
Diabetes Care. 1994 Nov;17(11):1281-9
pubmed: 7821168
Can J Neurol Sci. 1994 Nov;21(4):S3-7
pubmed: 7874610
N Engl J Med. 1993 Sep 30;329(14):977-86
pubmed: 8366922
Muscle Nerve. 1997 Jan;20(1):116-8
pubmed: 8995595
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
J Gen Intern Med. 1999 Jan;14 Suppl 1:S34-40
pubmed: 9933493